| 产品名称: | Human Coxsackievirus A 24 |
|---|---|
| 商品货号: | TS213341 |
| Classification: | Picornaviridae, Enterovirus, Human enterovirus C |
| Deposited As: | Coxsackievirus A24 |
| Agent: | Human Coxsackievirus A 24 |
| Strain: | Coxsackievirus A24 antiserum V-027-501-563 |
| Biosafety Level: | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation: | Source of antibody: Rhesus monkey |
| Product Format: | freeze-dried |
| Comments: | Immunogen: Picornavirus, Enterovirus, Coxsackievirus A24, Strain Joseph Source of antibody: Rhesus monkey Propagated in: human amnion cells in tissue culture Adjuvant: 1 part Arlacel A plus 9 parts Bayol F with equal amounts of undiluted suspension of virus |
| Name of Depositor: | NIH/NIAID |
| References: | Melnick JL, Ledinko N. Immunological reactions of the Coxsackie viruses. I. The neutralization test; technic and application. J. Exp. Med. 92: 463-482, 1950. PubMed: 14778925 Kamitsuka PS, et al. Preparation and standardization of Coxsackievirus reference antisera. I. For twenty-four group A viruses. Am. J. Epidemiol. 81: 283-306, 1965. PubMed: 14294414 |